Gangrene

Phase 3 trials (2)

• peripheral blood lymphocytes
• allogeneic adipose derived mesenchymal stem cell

Phase 1 trials (1)

• autologous bone marrow derived mesenchymal cells

Organization Involved with Phase 3 Indications (7)

• Atox Bio Ltd
• Mahidol University
• University of Heidelberg
• Harborview Injury Prevention and Research Center
• Franziskus Hospital, Berlin
• Department of Health and Human Services
• Stiftungsklinikum Boppard

Organization Involved with Phase 2 Indications (4)

• CSL Behring
• Kobe University
• Translational Research Informatics Center, Kobe, Hyogo, Japan
• University of Copenhagen

Organization Involved with Phase 1 Indications (1)

• South China Research Center for Stem Cell and Regenerative Medicine

Organization Involved with Other Experimental Indications (2)

• Cubist
• University of Maryland